NPI: 1639172869 · FAYETTEVILLE, NC 28304 · General Acute Care Hospital · NPI assigned 05/23/2005
Authorized official FISER, JOSEPH controls 20+ related entities in our dataset. Read more
| Authorized Official | FISER, JOSEPH (VP MANAGED CARE AND REVENUE CYCLE) |
| NPI Enumeration Date | 05/23/2005 |
Other providers sharing the same authorized official: FISER, JOSEPH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 223,896 | $9.02M |
| 2019 | 344,896 | $8.46M |
| 2020 | 235,340 | $6.38M |
| 2021 | 270,115 | $9.03M |
| 2022 | 312,196 | $12.47M |
| 2023 | 330,523 | $14.35M |
| 2024 | 306,905 | $16.08M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 140,809 | 120,214 | $22.14M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 70,377 | 57,580 | $14.97M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 100,258 | 89,223 | $8.40M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 70,517 | 60,979 | $2.92M |
| G0378 | Hospital observation service, per hour | 10,001 | 6,091 | $2.67M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 16,736 | 14,987 | $2.53M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,533 | 4,461 | $1.55M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 59,572 | 42,494 | $1.26M |
| 70450 | Computed tomography, head or brain; without contrast material | 5,134 | 4,115 | $1.07M |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 5,579 | 5,143 | $1.02M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 21,574 | 17,336 | $958K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37,966 | 32,560 | $917K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33,726 | 28,845 | $885K |
| 80053 | Comprehensive metabolic panel | 114,146 | 84,934 | $871K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3,558 | 3,027 | $796K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 6,810 | 5,433 | $674K |
| 71046 | Radiologic examination, chest; 2 views | 16,523 | 13,873 | $612K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 29,056 | 20,704 | $554K |
| 85027 | 99,915 | 75,423 | $507K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 11,834 | 9,502 | $493K |
| J3490 | Unclassified drugs | 257,738 | 71,325 | $488K |
| 87428 | 6,085 | 5,746 | $480K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 6,909 | 3,304 | $479K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 8,083 | 3,616 | $477K |
| 81025 | 55,668 | 47,869 | $404K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 21,731 | 16,082 | $391K |
| 71045 | Radiologic examination, chest; single view | 15,154 | 12,106 | $333K |
| 36415 | Collection of venous blood by venipuncture | 178,134 | 119,949 | $309K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,396 | 4,593 | $299K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 49,212 | 33,649 | $291K |
| 84484 | 45,675 | 24,299 | $283K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 17,666 | 15,668 | $265K |
| 96375 | Therapeutic injection; each additional sequential IV push | 9,937 | 5,778 | $250K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1,780 | 1,649 | $247K |
| 80048 | Basic metabolic panel (calcium, ionized) | 33,625 | 24,860 | $216K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 210 | 102 | $205K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 6,335 | 3,043 | $198K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 385 | 305 | $180K |
| 83036 | Hemoglobin; glycosylated (A1C) | 16,223 | 14,429 | $174K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4,059 | 3,849 | $158K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 12,080 | 10,865 | $142K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 272 | 217 | $137K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5,589 | 4,925 | $136K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5,590 | 4,924 | $136K |
| 81001 | 43,803 | 36,295 | $133K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,782 | 1,540 | $129K |
| 87486 | 3,562 | 3,030 | $126K | |
| 87581 | 3,559 | 3,029 | $124K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,458 | 825 | $112K |
| 82947 | 29,056 | 20,369 | $111K | |
| 83690 | 17,729 | 14,569 | $108K | |
| 87070 | 10,747 | 9,435 | $105K | |
| A9270 | Non-covered item or service | 106,881 | 33,011 | $102K |
| 99205 | Prolong outpt/office vis | 1,122 | 1,080 | $92K |
| 0002A | 1,542 | 1,426 | $82K | |
| 84443 | Thyroid stimulating hormone (TSH) | 5,225 | 4,486 | $80K |
| 96361 | Intravenous infusion, hydration; each additional hour | 817 | 594 | $80K |
| 0001A | 1,575 | 1,476 | $75K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 101 | 81 | $67K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,398 | 1,223 | $65K |
| 93017 | 453 | 352 | $56K | |
| 74018 | 1,008 | 918 | $56K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2,054 | 1,900 | $52K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 3,696 | 3,024 | $52K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 887 | 298 | $50K |
| J1453 | Injection, fosaprepitant, 1 mg | 377 | 180 | $50K |
| 87088 | 5,254 | 4,626 | $45K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 765 | 744 | $44K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 941 | 553 | $40K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,076 | 1,007 | $40K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 466 | 221 | $37K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,159 | 5,580 | $37K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 208 | 171 | $36K |
| 81002 | 12,217 | 9,760 | $34K | |
| 81003 | 12,190 | 10,270 | $34K | |
| 96376 | 416 | 251 | $32K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 4,230 | 2,977 | $32K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,267 | 3,535 | $31K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,233 | 1,039 | $31K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1,499 | 1,288 | $30K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,872 | 1,525 | $29K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 104 | 99 | $29K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 935 | 831 | $29K |
| 80061 | Lipid panel | 2,876 | 2,267 | $28K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 8,869 | 6,948 | $28K |
| 84439 | 2,802 | 2,507 | $27K | |
| 84702 | 2,717 | 2,395 | $27K | |
| 76801 | 169 | 151 | $26K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,118 | 834 | $25K |
| 83735 | 5,222 | 3,513 | $24K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 426 | 127 | $23K |
| 88307 | 130 | 122 | $23K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 385 | 305 | $23K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 911 | 744 | $23K |
| 82728 | 2,038 | 1,630 | $22K | |
| J2785 | Injection, regadenoson, 0.1 mg | 277 | 201 | $22K |
| 76820 | 548 | 246 | $22K | |
| 80320 | 839 | 719 | $20K | |
| 96367 | 774 | 345 | $19K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 48 | 31 | $17K |
| 85730 | 4,534 | 3,523 | $16K | |
| 87400 | 1,051 | 719 | $15K | |
| 85018 | 5,409 | 5,250 | $13K | |
| 11043 | 104 | 63 | $12K | |
| 90837 | Psychotherapy, 53 minutes with patient | 346 | 249 | $12K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 99 | 81 | $12K |
| 85610 | 5,335 | 4,034 | $12K | |
| 87807 | 611 | 575 | $11K | |
| 86592 | 2,436 | 2,251 | $11K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,922 | 1,879 | $11K |
| 72125 | Computed tomography, cervical spine; without contrast material | 48 | 41 | $11K |
| 0003A | 222 | 207 | $11K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 750 | 699 | $9K |
| 99241 | 1,186 | 1,166 | $9K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 13,263 | 6,099 | $9K |
| 99215 | Prolong outpt/office vis | 149 | 142 | $9K |
| J7510 | Prednisolone oral, per 5 mg | 2,945 | 2,645 | $8K |
| 0071A | 143 | 136 | $8K | |
| 83550 | 1,291 | 956 | $8K | |
| 82077 | 5,729 | 2,665 | $7K | |
| 99245 | 338 | 324 | $7K | |
| 90834 | Psychotherapy, 45 minutes with patient | 271 | 215 | $6K |
| 86850 | 510 | 469 | $6K | |
| 94664 | 189 | 180 | $6K | |
| 43264 | 16 | 12 | $6K | |
| 87420 | 446 | 408 | $6K | |
| 80143 | 3,671 | 1,141 | $6K | |
| 87210 | 1,236 | 1,072 | $5K | |
| 80179 | 3,534 | 1,114 | $5K | |
| 83615 | 1,717 | 1,275 | $5K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 742 | 314 | $5K |
| 11044 | 28 | 14 | $5K | |
| C1769 | Guide wire | 52 | 37 | $5K |
| 86376 | 277 | 268 | $5K | |
| 0072A | 78 | 78 | $5K | |
| 80329 | 362 | 267 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 521 | 474 | $4K |
| 82607 | 258 | 222 | $4K | |
| J2704 | Injection, propofol, 10 mg | 837 | 582 | $4K |
| 43259 | 18 | 13 | $4K | |
| 95811 | 12 | 12 | $4K | |
| 86762 | 227 | 218 | $4K | |
| 86787 | 250 | 238 | $3K | |
| 82550 | 919 | 672 | $3K | |
| 94644 | 103 | 77 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 19 | 12 | $3K |
| 29581 | 75 | 44 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 71 | 39 | $3K |
| 86360 | 119 | 78 | $3K | |
| 83021 | 142 | 134 | $3K | |
| 86481 | 32 | 30 | $3K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 135 | 116 | $2K |
| 94760 | 132 | 63 | $2K | |
| 86900 | 648 | 566 | $2K | |
| 86901 | 647 | 565 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | 63 | 61 | $2K |
| 99402 | 210 | 193 | $2K | |
| 74330 | 17 | 13 | $2K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 160 | 89 | $2K |
| 80074 | 50 | 44 | $2K | |
| 0054A | 43 | 40 | $2K | |
| 73130 | 34 | 28 | $2K | |
| 87340 | 181 | 175 | $2K | |
| 87205 | 390 | 356 | $2K | |
| J3480 | Injection, potassium chloride, per 2 meq | 203 | 144 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 19 | 12 | $2K |
| 93296 | 75 | 72 | $2K | |
| 87077 | 263 | 213 | $2K | |
| 85007 | 747 | 478 | $2K | |
| C1877 | Stent, non-coated/non-covered, without delivery system | 16 | 12 | $2K |
| 0353U | 157 | 136 | $2K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 62 | 53 | $2K |
| 90832 | Psychotherapy, 30 minutes with patient | 93 | 77 | $1K |
| 84681 | 66 | 59 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 678 | 483 | $1K |
| 73090 | 14 | 12 | $1K | |
| 87536 | 141 | 93 | $1K | |
| 96417 | 35 | 13 | $1K | |
| 84145 | 38 | 36 | $1K | |
| 82677 | 43 | 38 | $1K | |
| 86140 | 151 | 143 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 50 | 44 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 13 | 12 | $1K |
| 86255 | 69 | 66 | $1K | |
| 83516 | 69 | 66 | $967.72 | |
| 73562 | 21 | 16 | $905.71 | |
| 83525 | 47 | 41 | $860.92 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 206 | 98 | $850.73 |
| 73610 | 12 | 12 | $843.04 | |
| 0004A | 20 | 14 | $832.80 | |
| 0052A | 20 | 19 | $828.67 | |
| 86336 | 43 | 38 | $785.21 | |
| 82784 | 69 | 66 | $784.97 | |
| 82105 | 43 | 38 | $783.36 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 37 | 32 | $751.92 |
| 52310 | 12 | 12 | $712.76 | |
| 0053A | 13 | 13 | $711.79 | |
| 96402 | 33 | 25 | $686.71 | |
| 82043 | 129 | 121 | $686.10 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 329 | 257 | $681.19 |
| 72100 | 13 | 13 | $680.68 | |
| 83605 | 85 | 60 | $680.38 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 152 | 115 | $671.48 |
| 82570 | 129 | 121 | $613.00 | |
| 82553 | 109 | 74 | $603.26 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 198 | 141 | $585.70 |
| 99243 | 51 | 50 | $579.90 | |
| 74019 | 12 | 12 | $566.86 | |
| 96415 | 12 | 12 | $551.34 | |
| 82950 | 91 | 90 | $528.46 | |
| 84466 | 64 | 52 | $518.53 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 28 | 25 | $507.38 |
| J2060 | Injection, lorazepam, 2 mg | 278 | 120 | $499.64 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 27 | 18 | $486.85 |
| G0008 | Administration of influenza virus vaccine | 35 | 33 | $359.53 |
| 82180 | 39 | 27 | $320.32 | |
| 87040 | 24 | 24 | $308.64 | |
| 83880 | 16 | 12 | $292.22 | |
| 82248 | 106 | 79 | $276.80 | |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 17 | 13 | $248.91 |
| J1630 | Injection, haloperidol, up to 5 mg | 67 | 45 | $231.42 |
| 83540 | 46 | 28 | $218.16 | |
| 82565 | 64 | 58 | $209.82 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 103 | 63 | $203.72 |
| 95886 | 12 | 12 | $170.04 | |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 254 | 143 | $169.30 |
| 83921 | 14 | 12 | $168.39 | |
| 84100 | 87 | 34 | $163.14 | |
| 85014 | 93 | 68 | $147.25 | |
| 87220 | 28 | 26 | $122.13 | |
| 84156 | 18 | 14 | $119.10 | |
| 86403 | 12 | 12 | $114.30 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 30 | 25 | $109.45 |
| 87186 | 24 | 13 | $96.93 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 39 | 12 | $79.69 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 18 | 16 | $59.53 |
| 83986 | 13 | 12 | $47.64 | |
| 51798 | 30 | 25 | $40.28 | |
| 90686 | 54 | 32 | $3.22 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 289 | 230 | $0.00 |
| 36591 | 33 | 13 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 610 | 396 | $0.00 |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | 85 | 85 | $0.00 |